Patent · US Active

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

US8829052B2 · kind B2 · utility

0Cited by

11References

23Claims

0Family size

Assignee

Ardea Biosciences, Inc · US

Inventors

Andreas Maderna · Stony Point, US
Jean-Michel Vernier · Laguna Niguel, US
Dinesh Barawkar · Lake Forest, US
Varaprasad Chamakura · Irvine, US
Hassan El Abdellaoul · High Point, US
Zhi Hong · Chapel Hill, US

Key dates

Filing date	Sep 23, 2011
Grant date	Sep 9, 2014
Priority date	—
Expiry date	Sep 23, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.